Apogem Capital’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-4,577
Closed -$580K 210
2021
Q3
$580K Sell
4,577
-712
-13% -$104K 0.37% 99
2021
Q2
$880K Sell
5,289
-379
-7% -$61.4K 0.56% 64
2021
Q1
$1.03M Sell
5,668
-2,877
-34% -$667K 0.7% 44
2020
Q4
$1.71M Buy
+8,545
New +$1.74M 1.14% 24

Other funds holding TDOC

Apogem Capital's TDOC Position: Q4 2021 in Review

Apogem Capital sold out of Teladoc Health (TDOC) in Q4 2021, closing a stake of 4,577 shares — an estimated $580K sold.

Apogem Capital first reported a position in TDOC in Q4 2020 and held it in 4 quarters. The position peaked at $1.71M in Q4 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Apogem Capital reported no remaining Teladoc Health position as of Q4 2021 after selling out during the quarter.
  • Apogem Capital sold 4,577 Teladoc Health shares in Q4 2021, an estimated $580K.
  • Apogem Capital first reported a position in Teladoc Health in Q4 2020 and held it in 4 quarters.
  • Apogem Capital's Teladoc Health position peaked at $1.71M in Q4 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Apogem Capital's 13F filing for Q4 2021, filed 14 Feb 2022.